Skip to main content

National Institutes of Health — Portfolio, Page 20

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

491
Companies
$2.5B
Total invested
$5.9M
Avg. check
48
Industries
Health Care 15Biotechnology 13Medical Device 5Health Diagnostics 4Therapeutics 4Software 4+42 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 457480 of 491
Celldom, Inc
January 2021

Find and study cells that make diseases incurable

Biotechnology · DurhamSeed
Intake Health
September 2020

A continuous, passive, home-health remote monitoring platform.

Health Care · Raleigh$1.0M Grant
Gooddler
September 2020

GOODdler - connecting local needs with local resources

Small and Medium Businesses · San Francisco$55K Seed
Enrich Therapeutics
August 2020

Enrich Therapeutics is a biotechnology startup.

Biotechnology · Worcester$1.7M Grant
Scioto Biosciences
August 2020

Scioto is a developer of Activated Bacterial Therapeutics platform.

Biotechnology · Indianapolis$26.5M Series B
OneClick.chat
July 2020

OneClick.chat is an innovative video chat platform.

Information Technology · Philadelphia$1.8M Grant
Haima Therapeutics
May 2020

Haima Therapeutics is a pre-clinical stage biotechnology company.

Biotechnology · Cleveland$949K Grant
HeartVista
April 2020

HeartVista is a medical technology company.

Artificial Intelligence (AI) · Los Altos$8.7M Series A
CinderBio
April 2020

CinderBio produces the world's most stable enzymes from amazing microbes that thrive in hot acidic volcanic waters around the globe.

Biotechnology · San Leandro$1.7M Grant
Cicero Diagnostics
February 2020

Cicero Diagnostics is a women’s healthcare diagnostic company.

Health Care · Huntington Beach$1.0M Grant
Theraly Fibrosis
January 2020

Theraly is a preclinical-stage company whose mission is to develop innovative treatments for various forms of fibrotic disease.

Biopharma · Germantown$3.9M Grant
FIRMM
December 2019

FIRMM is a real-time MRI quality metrics to reduce costs and improve quality. Jointly developed by the Fair (OHSU) & Dosenbach (WashU) labs.

Analytics · St Louis$6.6M Series Unknown
AirSpeQ
September 2019

Improving the world for animals, plants and people by commercializing sensors for fine and ultra fine airborne particulate matter detection.

Aerospace · Berkeley$745K Grant
Infondrian
September 2019

Infondrian provides data-driven insights for cancer care.

Health Care · New York$1.8M Seed
scibac
July 2019

SciBac is a developer of biotherapeutics intended to treat antibiotic diseases.

Biotechnology · Burlingame$287K Grant
UroDev Medical
July 2019

UroDev Medical is develops a fully-internal, smart catheter for bladder management.

Impact Investing · Minneapolis$3.6M Grant
Embolx
June 2019

Embolx is a medical device start-up that manufactures and sells novel embolization microcatheters to treat cancer.

Health Care · SunnyvaleSeed
Symic Biomedical
April 2019

SYMIC Biomedical operates in the healthcare industry focusing on biotechnology business.

Biotechnology · Emeryville$11.0M Series C
Precision Virologics
March 2019

Precision Virologics is a St. Louis-based biotech startup.

Biotechnology · Saint Louis$300K Grant
CerSci Therapeutics
March 2019

CerSci Therapeutics is poised to deliver a new generation of non-opioid medicines to treat acute and chronic pain.

Biopharma · Dallas$8.0M Series A
DILIsym Services
January 2019

DILIsym Services provides drug-induced liver injury simulation software and related consulting services.

Biotechnology · Durham$1.5M Grant
Wicked Device
November 2018

Wicked Device is a Works member company.

Health Care · Ithaca$1.7M Grant
Epivax Oncology
June 2018

Epivax Oncology is a providence, RI and NY-based precision cancer immunotherapy company.

Biotechnology · Providence$1.2M Series Unknown
MenoGeniX
May 2018

MenoGeniX is a clinical stage biotechnology company focusing on the development of drugs for menopause.

Biotechnology · AuroraGrant

Where National Institutes of Health invests

Health Care15
Biotechnology13
Medical Device5
Health Diagnostics4
Therapeutics4
Software4

About National Institutes of Health's portfolio

How many companies has National Institutes of Health invested in?

National Institutes of Health has invested in 491 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does National Institutes of Health invest in?

National Institutes of Health's top investment sectors include Health Care, Biotechnology, Medical Device, Health Diagnostics, Therapeutics. The firm invests across 48 different industry categories.

What is National Institutes of Health's largest investment?

Among tracked funding rounds, Scioto Biosciences received $26.5M in a Series B round. National Institutes of Health's total known invested capital is $2.5B.

What is the average investment size for National Institutes of Health?

National Institutes of Health's average investment size is $5.9M across its portfolio of 491 companies.

What are National Institutes of Health's most recent investments?

Recent National Institutes of Health portfolio additions include Celldom, Inc, Intake Health, Gooddler, Enrich Therapeutics, Scioto Biosciences. These companies were founded in 2020 or later.

Reach the founders behind these 491 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →